An interventional study of Soft lens in Myopia, sponsored by Tianjin Eye Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-07-27.
Sponsored by Tianjin Eye Hospital · Not applicable, Interventional, and Other
To evaluate whether there is a difference in subjective and objective fit of soft lenses with different sagittal height
1,007 studies on the registry are indexed under Myopia; 210 are open to participants now.
This study's planned enrollment of 60 is below the median of 80 across 803 interventional studies indexed under Myopia.
Browse Myopia studies →Tianjin Eye Hospital is the lead sponsor of 52 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Toric soft lens with high sagittal height
Device: Soft lens
Toric soft lens with low sagittal height
Device: Soft lens
Spherical soft lens with high sagittal height
Device: Soft lens
Spherical soft lens with low sagittal height
Device: Soft lens
Traditional spherical soft lens
Device: Soft lens
Patients were randomly fitted with five different designs of soft lenses
Subjective questionnaire
The subjective questionnaire is a visual quality questionnaire developed by combining previous research and clinical symptoms, including whether there is foreign body sensation, pain, dry eyes, etc.The score ranges from 0 to 4, with the higher the score, the more obvious the symptoms
Time frame: 1 day (Once time after wearing the soft lens)
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tianjin Eye Hospital